Neurologic

International Stroke Conference (ISC) 2025

Congress Details

February 5-7, 2025

Los Angeles, CA, USA

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Congress Materials

ISC25-cAPPricorn1-design_POS_D3_v8.0_29Jan_DIGITAL

Presentation Type

Poster

Location

Los Angeles, CA, USA

Title

A Phase 2 Study Evaluating the Effects of Mivelsiran, an Investigational RNA Interference Therapeutic, on Hemorrhagic and Nonhemorrhagic Manifestations of Cerebral Amyloid Angiopathy

ISC_CAA-Preclinical-Rodent-Presentation_FINAL

Presentation Type

Presentation

Location

Los Angeles, CA, USA

Title

Targeting Cerebral Amyloid Angiopathy at its Source: An Amyloid Beta Precursor Protein-Targeted siRNA Reduced Vascular Amyloid Beta and Hemorrhage in Rodent Models